Christopher Stanley - Aeolus Pharmaceuticl VP Operations

AOLS Stock

USD 0.0001 0.00 0.00%

Insider

Christopher Stanley is VP Operations of Aeolus Pharmaceuticl

Phone	949-481-9825
Web	https://www.aeoluspharma.com

Aeolus Pharmaceuticl Management Efficiency

The company has return on total asset (ROA) of (0.903) % which means that it has lost $0.903 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8643) %, meaning that it created substantial loss on money invested by shareholders. Aeolus Pharmaceuticl's management efficiency ratios could be used to measure how well Aeolus Pharmaceuticl manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Aeolus Pharmaceuticl to Peers

Predict price of Aeolus Pharmaceuticl

Similar Executives

Showing other executives			INSIDER Age
	MD ODonnell	Tactile Systems Technology	N/A
	Jonathan Paris	Rapid Micro Biosystems	48
	Naum Muchnik	Icecure Medical	48
	Janelle Strop	Tactile Systems Technology	N/A
	Moria Ankri	Brainsway	40
	Eyal Shamir	Icecure Medical	63
	Ronen CPA	Icecure Medical	55
	Nikolai Kabelev	STRATA Skin Sciences	48
	Yiftach Roth	Brainsway	53
	Darrell Rigel	STRATA Skin Sciences	73
	Avner Hagai	Brainsway	68
	Soren Sinay	Venus Concept	53
	Shunichi Kuroda	Bone Biologics Corp	N/A
	Domenic Penna	Venus Concept	62
	Richard Ginn	Tenon Medical	58
	Eric Pauls	Tactile Systems Technology	49
	Jennifer Ernst	Tivic Health Systems	56
	Victoria Vezina	Rapid Micro Biosystems	56
	Michael Goodman	STRATA Skin Sciences	N/A
	Pr Zangen	Brainsway	54
	Christopher Jako	Brainsway	55

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. Aeolus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people. Aeolus Pharmaceuticl [AOLS] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

	Return On Equity	-1.86
	Return On Asset	-0.9

Aeolus Pharmaceuticl Leadership Team

Elected by the shareholders, the Aeolus Pharmaceuticl's board of directors comprises two types of representatives: Aeolus Pharmaceuticl inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aeolus. The board's role is to monitor Aeolus Pharmaceuticl's management team and ensure that shareholders' interests are well served. Aeolus Pharmaceuticl's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aeolus Pharmaceuticl's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Christopher Stanley, VP Operations
	John McManus, CEO and Pres

Aeolus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Aeolus Pharmaceuticl a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-1.86
	Return On Asset	-0.9
	Operating Margin	(5.31) %
	Current Valuation	167.29 K
	Shares Outstanding	152.09 M
	Price To Earning	(2.37) X
	Price To Book	0.81 X
	Price To Sales	0.22 X
	Revenue	2.08 M
	Gross Profit	(805 K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aeolus Pink Sheet Analysis

When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC